BRPI0907492A2 - derivados amida como moduladores alostéricos positivos e métodos de sua utilização - Google Patents
derivados amida como moduladores alostéricos positivos e métodos de sua utilizaçãoInfo
- Publication number
- BRPI0907492A2 BRPI0907492A2 BRPI0907492A BRPI0907492A BRPI0907492A2 BR PI0907492 A2 BRPI0907492 A2 BR PI0907492A2 BR PI0907492 A BRPI0907492 A BR PI0907492A BR PI0907492 A BRPI0907492 A BR PI0907492A BR PI0907492 A2 BRPI0907492 A2 BR PI0907492A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- amide derivatives
- positive allosteric
- allosteric modulators
- modulators
- Prior art date
Links
- 230000003281 allosteric effect Effects 0.000 title 1
- 150000001408 amides Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2688608P | 2008-02-07 | 2008-02-07 | |
| US14362809P | 2009-01-09 | 2009-01-09 | |
| PCT/US2009/033329 WO2009100294A2 (en) | 2008-02-07 | 2009-02-06 | Amide derivatives as positive allosteric modulators and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0907492A2 true BRPI0907492A2 (pt) | 2017-06-13 |
Family
ID=40952708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0907492A BRPI0907492A2 (pt) | 2008-02-07 | 2009-02-06 | derivados amida como moduladores alostéricos positivos e métodos de sua utilização |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8536221B2 (pt) |
| EP (1) | EP2250162B1 (pt) |
| JP (1) | JP2011511800A (pt) |
| KR (1) | KR20100124272A (pt) |
| CN (1) | CN101990537A (pt) |
| AU (1) | AU2009212259A1 (pt) |
| BR (1) | BRPI0907492A2 (pt) |
| CA (1) | CA2713519A1 (pt) |
| CO (1) | CO6290763A2 (pt) |
| CR (1) | CR11664A (pt) |
| DO (1) | DOP2010000241A (pt) |
| EC (1) | ECSP10010465A (pt) |
| IL (1) | IL207332A0 (pt) |
| MX (1) | MX2010008714A (pt) |
| RU (1) | RU2010137114A (pt) |
| WO (1) | WO2009100294A2 (pt) |
| ZA (1) | ZA201005514B (pt) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9108948B2 (en) | 2006-06-23 | 2015-08-18 | Abbvie Inc. | Cyclopropyl amine derivatives |
| BRPI0712823A2 (pt) | 2006-06-23 | 2012-07-24 | Abbott Lab | derivados de ciclopropil amina como moduladores de receptor de histamina h3 |
| TW201004939A (en) * | 2008-04-17 | 2010-02-01 | Glaxo Group Ltd | Novel compounds |
| EP2419420B1 (en) * | 2009-04-16 | 2013-03-13 | Proximagen Limited | Indole derivative modulators of the alpha 7 nachr |
| US9186353B2 (en) | 2009-04-27 | 2015-11-17 | Abbvie Inc. | Treatment of osteoarthritis pain |
| WO2012037258A1 (en) | 2010-09-16 | 2012-03-22 | Abbott Laboratories | Processes for preparing 1,2-substituted cyclopropyl derivatives |
| TW201245185A (en) | 2011-04-01 | 2012-11-16 | Lundbeck & Co As H | New positive allosteric modulators of nicotinic acetylcholine receptor |
| AR086791A1 (es) | 2011-07-01 | 2014-01-22 | Lundbeck & Co As H | Moduladores alostericos positivos del receptor de acetilcolina nicotinico |
| WO2014049133A1 (en) * | 2012-09-28 | 2014-04-03 | H. Lundbeck A/S | New positive allosteric modulators of nicotinic acetylcholine receptor |
| CN110627770A (zh) | 2013-11-18 | 2019-12-31 | 福马疗法公司 | 作为bet溴域抑制剂的四氢喹啉组成物 |
| RU2720237C2 (ru) | 2013-11-18 | 2020-04-28 | Форма Терапеутикс, Инк. | Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет |
| EP3623371A1 (en) | 2014-12-16 | 2020-03-18 | Axovant Sciences GmbH | Geminal substituted quinuclidine amide compounds as agonists of alpha-7 nicotinic acetylcholine receptors |
| CN107847494A (zh) | 2015-06-10 | 2018-03-27 | 阿考温特科学股份有限公司 | 作为α7‑烟碱乙酰胆碱受体激动剂的氨基苯并异噁唑化合物 |
| JP2018523707A (ja) | 2015-08-12 | 2018-08-23 | アクソバント サイエンシズ ゲーエムベーハー | α７−ニコチン性アセチルコリン受容体のアゴニストとしてのジェミナル置換アミノベンゾイソオキサゾール化合物 |
| EP3419973B1 (en) * | 2016-02-24 | 2020-04-08 | Acesion Pharma ApS | Novel potassium channel inhibitors |
| AR108586A1 (es) | 2016-06-10 | 2018-09-05 | Lilly Co Eli | Compuestos de 2,3-dihidro-1h-indol |
| AU2017298644B2 (en) * | 2016-07-18 | 2021-05-06 | Oat Agrio Co., Ltd. | Novel benzylamide compound, method for producing the same, and miticide |
| WO2018051252A2 (en) * | 2016-09-15 | 2018-03-22 | Insecticides (India) Limited | Novel amide compound, method for producing the same, and miticide |
| HU231478B1 (hu) | 2018-07-13 | 2024-02-28 | Richter Gedeon Nyrt. | Szubsztituált (aza)indol származékok |
| HU231333B1 (hu) | 2018-07-13 | 2023-01-28 | Richter Gedeon Nyrt | Spirokromán származékok |
| HU231414B1 (hu) | 2018-07-13 | 2023-08-28 | Richter Gedeon Nyrt. | Tiadiazin származékok |
| WO2020096871A1 (en) * | 2018-11-06 | 2020-05-14 | Merck Sharp & Dohme Corp. | Novel substituted tricyclic compounds as indoleamine 2,3-dioxygenase inhibitors |
| CN115151540A (zh) | 2019-12-02 | 2022-10-04 | 风暴治疗有限公司 | 作为mettl3抑制剂的多杂环化合物 |
| CN118496159B (zh) * | 2024-07-18 | 2024-09-24 | 广州医科大学附属市八医院 | 一种化合物在制备具有预防和/或治疗肝纤维化作用的药物中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3092946B2 (ja) | 1995-12-14 | 2000-09-25 | メルク エンド カンパニー インコーポレーテッド | ゴナドトロピン放出ホルモン拮抗剤 |
| GB9919411D0 (en) * | 1999-08-18 | 1999-10-20 | Zeneca Ltd | Chemical compounds |
| US6306890B1 (en) | 1999-08-30 | 2001-10-23 | Vanderbilt University | Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors |
| SE9903997D0 (sv) * | 1999-11-03 | 1999-11-03 | Astra Ab | New compounds |
| DE10217006A1 (de) | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
| EP1785425B1 (en) | 2002-09-30 | 2009-03-25 | NeuroSearch A/S | 1,4-Diazabicycloalkane derivatives, their preparation and use |
| BRPI0409241A (pt) | 2003-04-10 | 2006-03-28 | Pfizer | compostos bicìclicos como antagonistas do receptor de nr2b, composições farmacêuticas compreendendo os mesmos e seu uso |
| US20050065178A1 (en) | 2003-09-19 | 2005-03-24 | Anwer Basha | Substituted diazabicycloakane derivatives |
| US20050245531A1 (en) | 2003-12-22 | 2005-11-03 | Abbott Laboratories | Fused bicycloheterocycle substituted quinuclidine derivatives |
| US20050137204A1 (en) | 2003-12-22 | 2005-06-23 | Abbott Laboratories | Fused bicycloheterocycle substituted quinuclidine derivatives |
| US20060106011A1 (en) * | 2004-11-12 | 2006-05-18 | Bock Mark G | 2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation |
| WO2006060737A2 (en) | 2004-12-03 | 2006-06-08 | Takeda San Diego, Inc. | Mitotic kinesin inhibitors |
| SG176477A1 (en) * | 2006-08-07 | 2011-12-29 | Ironwood Pharmaceuticals Inc | Indole compounds |
-
2009
- 2009-02-06 JP JP2010546032A patent/JP2011511800A/ja not_active Withdrawn
- 2009-02-06 US US12/367,096 patent/US8536221B2/en not_active Expired - Fee Related
- 2009-02-06 AU AU2009212259A patent/AU2009212259A1/en not_active Abandoned
- 2009-02-06 EP EP09707625.1A patent/EP2250162B1/en active Active
- 2009-02-06 RU RU2010137114/04A patent/RU2010137114A/ru not_active Application Discontinuation
- 2009-02-06 MX MX2010008714A patent/MX2010008714A/es not_active Application Discontinuation
- 2009-02-06 BR BRPI0907492A patent/BRPI0907492A2/pt not_active IP Right Cessation
- 2009-02-06 KR KR1020107019897A patent/KR20100124272A/ko not_active Withdrawn
- 2009-02-06 CA CA2713519A patent/CA2713519A1/en not_active Abandoned
- 2009-02-06 WO PCT/US2009/033329 patent/WO2009100294A2/en not_active Ceased
- 2009-02-06 CN CN2009801122272A patent/CN101990537A/zh active Pending
-
2010
- 2010-08-01 IL IL207332A patent/IL207332A0/en unknown
- 2010-08-02 ZA ZA2010/05514A patent/ZA201005514B/en unknown
- 2010-08-04 DO DO2010000241A patent/DOP2010000241A/es unknown
- 2010-08-18 CO CO10101155A patent/CO6290763A2/es not_active Application Discontinuation
- 2010-09-01 CR CR11664A patent/CR11664A/es not_active Application Discontinuation
- 2010-09-06 EC EC2010010465A patent/ECSP10010465A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009100294A3 (en) | 2009-11-12 |
| US8536221B2 (en) | 2013-09-17 |
| EP2250162A2 (en) | 2010-11-17 |
| AU2009212259A1 (en) | 2009-08-13 |
| JP2011511800A (ja) | 2011-04-14 |
| CO6290763A2 (es) | 2011-06-20 |
| US20090270408A1 (en) | 2009-10-29 |
| IL207332A0 (en) | 2010-12-30 |
| DOP2010000241A (es) | 2010-08-31 |
| EP2250162A4 (en) | 2012-10-31 |
| CN101990537A (zh) | 2011-03-23 |
| KR20100124272A (ko) | 2010-11-26 |
| CA2713519A1 (en) | 2009-08-13 |
| EP2250162B1 (en) | 2014-03-19 |
| ECSP10010465A (es) | 2010-10-30 |
| ZA201005514B (en) | 2012-01-25 |
| MX2010008714A (es) | 2010-09-24 |
| WO2009100294A2 (en) | 2009-08-13 |
| RU2010137114A (ru) | 2012-03-20 |
| CR11664A (es) | 2011-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0907492A2 (pt) | derivados amida como moduladores alostéricos positivos e métodos de sua utilização | |
| LTC2291080I2 (lt) | Sfingozino fosfato receptorių nauji moduliatoriai | |
| EP2326631A4 (en) | MIF MODULATORS | |
| BR112013014119A2 (pt) | novos moduladores e métodos de uso | |
| BRPI0921992A2 (pt) | moduladores tgr5 e métodos de uso destes | |
| BRPI0812363A2 (pt) | Moduladores alostéricos positivos de mglurs de benzamida e métodos de preparação e utilização dos mesmos | |
| BRPI0906980A2 (pt) | Composição de derivados e maleatados | |
| BRPI0916735A2 (pt) | moduladores de tgr5 e métodos de uso do mesmo | |
| BRPI0921983A2 (pt) | moduladores tgr5 e métodos de uso dos mesmos | |
| BRPI0922180A2 (pt) | insoindolinona e análogos correlatos como moduladores de sirtuína | |
| HRP20151052T1 (xx) | Peteroäślani heterocikliäśki amidi i srodne tvari | |
| EP2259678A4 (en) | PROTEIN KINASE MODULATORS | |
| CO6950474A2 (es) | Derivados de quinolina carboxamida y quinolina carbonitrilo como moduladores alostéricos negativos de mglur2, composiciones, y su uso | |
| HUE046932T2 (hu) | Argináz inhibitorok és felhasználási eljárások | |
| PT2496691T (pt) | Composições de nucleases terapêuticas e métodos | |
| EP2547676A4 (en) | MODULATORS OF THE HEC1 ACTIVITY AND METHOD THEREFOR | |
| EP2512245A4 (en) | POSITIVE ALLOSTERIC PYRIDOCHINOLICIDIDINE M1 RECEPTOR MODULATORS | |
| EP2344484A4 (en) | S1P RECEPTOR MODULATORS AND THEIR USE | |
| EP2575954A4 (en) | ELECTROPORATION ELECTRODE CONFIGURATION AND METHOD THEREFOR | |
| IL229239A0 (en) | Crystalline forms of dimethoxy docetaxel and methods for preparing the same | |
| EP2588104A4 (en) | POSITIVE ALLOSTERIC ISOINDOLON M1 RECEPTOR MODULATORS | |
| BRPI0918206A2 (pt) | derivados de animoéster e composição medicinal destes | |
| EP2244577A4 (en) | POSITIVE ALLOSTERIC CHINOLIZIDINONE M1 RECEPTOR MODULATORS | |
| EP2548599A4 (en) | DISPOSABLE KIT AND SPRAYER | |
| ECSP10010558A (es) | Tiazolopiridin-2-iloxi-fenil y tiazolopirazin-2-iloxi-fenil aminas como moduladores de la leucotrieno a4 hidrolasa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |